Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Annexon Biosciences
< Previous
1
2
Next >
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
June 04, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data
June 03, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
May 13, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Biosciences to Present at the Bank of America Health Care Conference
May 09, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
May 07, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
May 01, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
March 26, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
March 18, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach
February 21, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
February 20, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and Neurodegenerative Diseases
January 07, 2024
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 27, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
December 20, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint
December 20, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway
December 20, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
December 18, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference
November 22, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results
November 13, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Biosciences to Participate in 2023 Jefferies London Healthcare Conference
November 09, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Receives PRIME Designation from the EMA for ANX007 for the Treatment of Geographic Atrophy
October 24, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
October 18, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Announces Clinical and Regulatory Progress for ANX005 Pivotal Program in Guillain-Barré Syndrome (GBS)
October 10, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Biosciences to Participate in the 2023 Cantor Global Healthcare Conference
September 19, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
September 18, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Highlights Recent Pipeline and Business Progress and Reports Second Quarter 2023 Financial Results
August 07, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2023
From
Annexon Biosciences
Via
GlobeNewswire
Tickers
ANNX
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.